BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
Reading Time: 11 minutes San Mateo, Calif., United States: Five-year results of Phase 3 SEQUOIA study demonstrate durable benefits of BRUKINSA in patients with CLL Two oral presentations showcase promising safety and efficacy data for BTK chimeric degradation activation compound (CDAC), BGB-16673 Oral presentation highlights
DUG Foodtech announces the outcome of the rights issue
Reading Time: 7 minutes NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR IN ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR
Diageo India Releases 2024 ESG Reporting Index Highlights Achievements Across Its ‘Spirit of Progress’ Goals
Reading Time: 6 minutes Diageo India (United Spirits Ltd.), among the country’s leading alco-bev companies, launched its third annual ESG Reporting Index 2024 today, highlighting continued progress in the company’s ‘Spirit of Progress’ ESG action plan. The Reporting Index shares impacts across three key objectives outlined in Diageo’s Spirit
OCBC Forms Strategic Partnership With Ant International to Enhance the Efficiency of Cross-Border Fund Settlements Through Innovations in Tokenised Deposits
Reading Time: 3 minutes Singapore: OCBC and Ant International have formed a strategic partnership to enhance the efficiency and speed of cross-border fund settlements. In a Memorandum of Understanding (MoU) signed on 5 November 2024 by Melvyn Low, Head of Global Transaction Banking at OCBC,and
#24-379 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
Diamyd Medical and INNODIA partner for Type 1 Diabetes awareness and patient recruitment for the DIAGNODE-3 precision medicine trial
Reading Time: 3 minutes Diamyd Medical has entered a strategic partnership with INNODIA, an international non-profit organization dedicated to advancing research on disease modifying therapies for Type 1 Diabetes. The partnership will leverage INNODIA’s extensive EU-based clinical network with the aim to further amplify patient enrolment
SOFTSWISS Wins SBC Latinoamérica Award for Help Brazil Initiative
Reading Time: 2 minutes SOFTSWISS has won the Socially Responsible Initiative of the Year nomination at the SBC Awards Latinoamérica 2024 for its impactful ‘Help Brazil’ initiative. This recognition underscores the company’s support for Brazilian communities affected by severe flooding earlier this year and its dedication to
DanCann Pharma A/S: Capital reduction in DanCann Pharma A/S is completed
Reading Time: 3 minutes The capital reduction in DanCann Pharma A/S as resolved on an extraordinary general meeting held on 7 October 2024 has been completed today, 5 November 2024, following expiry of a 4-week notice period (“proklama”). As set out in press release published
Noble Corporation plc Announces Third Quarter 2024 Results and Additional Share Repurchase Authorization
Reading Time: 16 minutes • Closed Diamond acquisition on September 4th • Increased capital return program with additional share repurchase authorization of $400 million • Repurchased 6.9 million of shares in Q3 2024, $0.50 per share dividend declared for Q4 2024, bringing total FY 2024 cash
Synsam invites you to a video presentation of the Q3 report 2024 and a live Q&A session
Reading Time: 2 minutes Synsam AB (publ) will release its interim report for the third quarter 2024 on Tuesday, November 19th at 07:30. At the same time, the company will publish an interview with President and CEO Håkan Lundstedt, together with a presentation of the